Patents by Inventor Jagadish C. Sircar

Jagadish C. Sircar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical products from fungal strains
    Patent number: 10682380
    Abstract: Disclosed herein are compositions comprising an isolated cellulose degrading fungus and pharmaceutical substances produced by the fungus.
    Type: Grant
    Filed: August 12, 2016
    Date of Patent: June 16, 2020
    Assignee: Menon Renewable Products, Inc.
    Inventors: Suresh Menon, Samantha S Orchard, Jessica Badger, David Lipson, Sara Guidi, Jagadish C Sircar, Kashinatham Alisala
  • ANIMAL MEAL THAT INCLUDES FUNGAL BIOMASS
    Publication number: 20190127673
    Abstract: Disclosed herein are compositions comprising an isolated cellulose degrading fungus. Also disclosed are culture compositions and bioreactor compositions comprising the cellulose degrading fungus. Further described herein are filtration and extraction devices comprising the cellulose degrading fungus. Still further disclosed are bioprocessing facilities for and methods for producing co-products resulting from one or more bioprocesses of the cellulose degrading fungus.
    Type: Application
    Filed: June 11, 2018
    Publication date: May 2, 2019
    Inventors: Suresh M. Menon, Arul Victor Suresh, Samantha S. Orchard, Kashinatham Alisala, Jagadish C. Sircar, Sara Ingegard Hash
  • Animal meal that includes fungal biomass
    Patent number: 9994804
    Abstract: Disclosed herein are compositions comprising an isolated cellulose degrading fungus. Also disclosed are culture compositions and bioreactor compositions comprising the cellulose degrading fungus. Further described herein are filtration and extraction devices comprising the cellulose degrading fungus. Still further disclosed are bioprocessing facilities for and methods for producing co-products resulting from one or more bioprocesses of the cellulose degrading fungus.
    Type: Grant
    Filed: April 7, 2014
    Date of Patent: June 12, 2018
    Assignee: Menon Renewable Products, Inc.
    Inventors: Suresh M. Menon, Arul Victor Suresh, Samantha S. Orchard, Kashinatham Alisala, Jagadish C. Sircar, Sara Ingegard Hash
  • PHARMACEUTICAL PRODUCTS FROM FUNGAL STRAINS
    Publication number: 20170065651
    Abstract: Disclosed herein are compositions comprising an isolated cellulose degrading fungus and pharmaceutical substances produced by the fungus.
    Type: Application
    Filed: August 12, 2016
    Publication date: March 9, 2017
    Inventors: Suresh Menon, Samantha S. Orchard, Jessica Badger, David Lipson, Sara Guidi, Jagadish C. Sircar, Kashinatham Alisala
  • Pharmaceutical products from fungal strains
    Patent number: 9415080
    Abstract: Disclosed herein are compositions comprising an isolated cellulose degrading fungus and pharmaceutical substances produced by the fungus.
    Type: Grant
    Filed: June 19, 2014
    Date of Patent: August 16, 2016
    Assignee: Menon Renewable Products, Inc.
    Inventors: Suresh Menon, Samantha S. Orchard, Jessica Badger, David Lipson, Sara Guidi, Jagadish C. Sircar, Kashinatham Alisala
  • Pharmaceutical products from fungal strains
    Patent number: 8932602
    Abstract: Disclosed herein are compositions comprising an isolated cellulose degrading fungus and pharmaceutical substances produced by the fungus.
    Type: Grant
    Filed: August 11, 2011
    Date of Patent: January 13, 2015
    Assignee: Menon Renewable Products, Inc.
    Inventors: Suresh M. Menon, Samantha S. Orchard, Jessica Badger, Sara Guidi, David Newman, Jagadish C. Sircar, Kashinatham Alisala
  • PHARMACEUTICAL PRODUCTS FROM FUNGAL STRAINS
    Publication number: 20140377303
    Abstract: Disclosed herein are compositions comprising an isolated cellulose degrading fungus and pharmaceutical substances produced by the fungus.
    Type: Application
    Filed: June 19, 2014
    Publication date: December 25, 2014
    Inventors: Suresh Menon, Samantha S. Orchard, Jessica Badger, David Lipson, Sara Guidi, David Newman, Jagadish C. Sircar, Kashinatham Alisala
  • ANIMAL MEAL THAT INCLUDES FUNGAL BIOMASS
    Publication number: 20140363536
    Abstract: Disclosed herein are compositions comprising an isolated cellulose degrading fungus. Also disclosed are culture compositions and bioreactor compositions comprising the cellulose degrading fungus. Further described herein are filtration and extraction devices comprising the cellulose degrading fungus. Still further disclosed are bioprocessing facilities for and methods for producing co-products resulting from one or more bioprocesses of the cellulose degrading fungus.
    Type: Application
    Filed: April 7, 2014
    Publication date: December 11, 2014
    Applicant: Menon Renewable Resources, Inc.
    Inventors: Suresh M. Menon, Arul Victor Suresh, Samantha S. Orchard, Kashinatham Alisala, Jagadish C. Sircar, Sara Ingegard Hash
  • Animal meal that includes fungal biomass
    Patent number: 8728550
    Abstract: Disclosed herein are compositions comprising an isolated cellulose degrading fungus. Also disclosed are culture compositions and bioreactor compositions comprising the cellulose degrading fungus. Further described herein are filtration and extraction devices comprising the cellulose degrading fungus. Still further disclosed are bioprocessing facilities for and methods for producing co-products resulting from one or more bioprocesses of the cellulose degrading fungus.
    Type: Grant
    Filed: May 6, 2011
    Date of Patent: May 20, 2014
    Assignee: Menon Renewable Resources, Inc.
    Inventors: Suresh M. Menon, Arul Victor Suresh, Samantha S. Orchard, Kashinatham Alisala, Jagadish C. Sircar, Sara Ingegard Hash
  • PHARMACEUTICAL PRODUCTS FROM FUNGAL STRAINS
    Publication number: 20130149333
    Abstract: Disclosed herein are compositions comprising an isolated cellulose degrading fungus and pharmaceutical substances produced by the fungus.
    Type: Application
    Filed: August 11, 2011
    Publication date: June 13, 2013
    Applicant: MENON & ASSOCIATES, INC.
    Inventors: Suresh M. Menon, Samantha S. Orchard, Jessica Badger, David Lipson, Sara Guidi, David Newman, Jagadish C. Sircar, Kashinatham Alisala
  • ANIMAL MEAL THAT INCLUDES FUNGAL BIOMASS
    Publication number: 20120052150
    Abstract: Disclosed herein are compositions comprising an isolated cellulose degrading fungus. Also disclosed are culture compositions and bioreactor compositions comprising the cellulose degrading fungus. Further described herein are filtration and extraction devices comprising the cellulose degrading fungus. Still further disclosed are bioprocessing facilities for and methods for producing co-products resulting from one or more bioprocesses of the cellulose degrading fungus.
    Type: Application
    Filed: May 6, 2011
    Publication date: March 1, 2012
    Applicant: MENON & ASSOCIATES, INC.
    Inventors: Suresh M. Menon, Arul Victor Suresh, Samantha S. Orchard, Kashinatham Alisala, Jagadish C. Sircar
  • Phenyl-indole compounds for modulating IgE and Inhibiting cellular proliferation
    Patent number: 7375118
    Abstract: The present invention is directed to small molecule inhibitors of the IgE response to allergens, which are useful in the treatment of allergy and/or asthma or any diseases where IgE is pathogenic. This invention also relates to phenyl-indole molecules that are cellular proliferation inhibitors and thus are useful as anticancer agents. This invention further relates to small molecules which suppress cytokines and leukocytes.
    Type: Grant
    Filed: September 12, 2003
    Date of Patent: May 20, 2008
    Assignee: Avanir Pharmaceuticals
    Inventors: Jagadish C. Sircar, Jailall Ramnauth, Mark L. Richards
  • Benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
    Patent number: 7282518
    Abstract: The present invention is directed to small molecule inhibitors of the IgE response to allergens, which are useful in the treatment of allergy and/or asthma or any diseases where IgE is pathogenic. This invention also relates to benzimidazole molecules that are cellular proliferation inhibitors and thus are useful as anticancer agents.
    Type: Grant
    Filed: March 5, 2004
    Date of Patent: October 16, 2007
    Assignee: Avanir Pharmaceuticals
    Inventors: Jagadish C. Sircar, Mark L. Richards
  • Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
    Patent number: 7256287
    Abstract: The present invention is directed to small molecule inhibitors of the IgE response to allergens, which are useful in the treatment of allergy and/or asthma or any diseases where IgE is pathogenic. This invention also relates to phenyl-aza-benzimidazole molecules that are cellular proliferation inhibitors and thus are useful as anticancer agents. This invention further relates to small molecules which suppress cytokines and leukocytes.
    Type: Grant
    Filed: September 12, 2003
    Date of Patent: August 14, 2007
    Assignee: Avanir Pharmaceuticals
    Inventors: Jagadish C. Sircar, Richard J. Thomas, Mark L. Richards, Anjana Sinha
  • Benzimidazole derivatives as modulators of IgE
    Patent number: 6919366
    Abstract: This invention relates to a family of benzimidazole analogs, which are inhibitors of the IgE response to allergens. These compounds are useful in the treatment of allergy, asthma, or any diseases where IgE is pathogenic.
    Type: Grant
    Filed: October 16, 2001
    Date of Patent: July 19, 2005
    Assignee: Avanir Pharmaceuticals
    Inventors: Jagadish C. Sircar, Mark L. Richards, Michael G. Campbell, Michael W. Major
  • Benzimidazole compounds for regulating IgE
    Patent number: 6911462
    Abstract: This invention relates to a family of phenylbenzimidazole analogs, which are inhibitors of the IgE response to allergens. These compounds are useful in the treatment of allergy and/or asthma or any diseases where IgE is pathogenic.
    Type: Grant
    Filed: March 20, 2002
    Date of Patent: June 28, 2005
    Assignee: Avanir Pharmaceuticals
    Inventors: Jagadish C. Sircar, Mark L. Richards, Michael G. Campbell, Michael W. Major
  • Imidazole derivatives for treatment of allergic and hyperproliferative disorders
    Publication number: 20040229927
    Abstract: The preferred embodiments are directed to small molecule inhibitors of the IgE response to allergens, which are useful in the treatment of allergy and/or asthma or any diseases where IgE is pathogenic. The preferred embodiments also relate to imidazole molecules that are cellular proliferation inhibitors and thus are useful as anticancer agents. The preferred embodiments further relate to small molecules which suppress cytokines and leukocytes.
    Type: Application
    Filed: April 9, 2004
    Publication date: November 18, 2004
    Inventors: Jagadish C. Sircar, Richard J. Thomas, Mark L. Richards, Haripada Khatuya
  • Benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
    Publication number: 20040214821
    Abstract: The present invention is directed to small molecule inhibitors of the IgE response to allergens, which are useful in the treatment of allergy and/or asthma or any diseases where IgE is pathogenic. This invention also relates to benzimidazole molecules that are cellular proliferation inhibitors and thus are useful as anticancer agents.
    Type: Application
    Filed: March 5, 2004
    Publication date: October 28, 2004
    Inventors: Jagadish C. Sircar, Mark L. Richards
  • Phenyl-indole compounds for modulating IgE and inhibiting cellular proliferation
    Publication number: 20040180946
    Abstract: The present invention is directed to small molecule inhibitors of the IgE response to allergens, which are useful in the treatment of allergy and/or asthma or any diseases where IgE is pathogenic. This invention also relates to phenyl-indole molecules that are cellular proliferation inhibitors and thus are useful as anticancer agents. This invention further relates to small molecules which suppress cytokines and leukocytes.
    Type: Application
    Filed: September 12, 2003
    Publication date: September 16, 2004
    Inventors: Jagadish C. Sircar, Jailall Ramnauth, Mark L. Richards
  • Benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
    Patent number: 6759425
    Abstract: The present invention is directed to small molecule inhibitors of the IgE response to allergens, which are useful in the treatment of allergy and/or asthma or any diseases where IgE is pathogenic. This invention also relates to benzimidazole molecules that are cellular proliferation inhibitors and thus are useful as anticancer agents.
    Type: Grant
    Filed: February 27, 2002
    Date of Patent: July 6, 2004
    Assignee: Avanir Pharmaceuticals
    Inventors: Jagadish C. Sircar, Mark L. Richards